New Deal
SAVED SEARCHES
NO SAVED SEARCHES
Automate your research and never miss a deal that matters to you.
Deals (43)
Dealmakers
Service Providers
Funds
Corporates
FILTER
0
Value
Date
Country
Sector
Deal Type
Export
SORT
Announcement Date
Deal Value
Alterome Therapeutics
Goldman Sachs Asset Management
£105m
5 dealmakers
Homology Medicines
Q32 Bio
£92m
12 dealmakers
Cartesian Therapeutics
Selecta Biosciences
value n/a
22 dealmakers
Lung Therapeutics
Aileron Therapeutics
8 dealmakers
Mariana Oncology
Deep Track Capital
£139m
ABCURO
Redmile Group
£121m
17 dealmakers
Neoleukin Therapeutics
Neurogene
£282m
6 dealmakers
Travere Therapeutics (bile Acid Product Portfolio)
Mirum Pharmaceuticals
£366m
32 dealmakers
Diffusion Pharmaceuticals
Eip Pharma
10 dealmakers
Milestone Pharmaceuticals
Rtw Investments
£100m
4 dealmakers
CODAGENIX
Serum Institute Of India
£20m
9 dealmakers
Flame Biosciences
Leap Therapeutics
3 dealmakers
Graybug Vision
CALCIMEDICA
40 dealmakers
Enliven Therapeutics
IMARA
41 dealmakers
OPTHEA
The Carlyle Group
£140m
Theravance Respiratory Company
Royalty Pharma
£1,353m
31 dealmakers
La Jolla Pharmaceutical
Innoviva
£124m
Satiogen Pharmaceuticals
Entasis Therapeutics
£36m
28 dealmakers
Lygos
Flexible Solutions International
Antares Pharma
HALOZYME
£737m
59 dealmakers
Cdr-life
Omega Funds
£60m
Congruence Therapeutics
Amplitude Ventures
Pear Therapeutics
Arboretum Ventures
£864m
44 dealmakers
Caris Life Sciences
T. Rowe Price Group
£589m
Tango Therapeutics
Cormorant Asset Management
£257m
Omega Therapeutics
Logos Capital
£91m
Tscan Therapeutics
6 Dimensions Capital
£73m
11 dealmakers
Ikena Oncology
£88m
15 dealmakers
Cadent Therapeutics
Novartis
£576m
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.